Contact Dominique Cote

Background

Dominique Côté brings 30 years of experience leading commercial teams in global pharmaceutical and biotech organisations.

In 2018, she founded her own advisory group, Cosawi and focuses on strategic busines transformation and commercial excellence, executive coaching and leadership, SAM roadmaps, process and tools as well as account based marketing.

She brings together the marriage of science, business and customer centric approach as her core focus with leaders and teams.

Prior to starting her consultancy firm, she served as a commercial executive within lifesciences companies such as Novartis, Pfizer and UCB leading global go to market transformations, KAM/SAM journeys, commercial excellence and general managment. She also led global marketing and innovation for big pharma and biotech groups.

Her career provided her with global/varied market experience and diversified culture knowledge. She managed teams in more than 36 countries, leading activities to optimise profitability and effectiveness of commercial strategies, as well as enabling deployment of new commercial and go to market business models.

In 2023, Dominique was awarded the recognition of Business Transformation CEO of the year by the Influential Businesswomen Group.

Dominique lives between Montreal and Brussels, Belgium to stay close to her global clients. She speaks French and English.

Current activities

Dominque is an accomplished busines leader, recognised as a chief architect of global account program journeys, leading corporate changes and cultural shifts for customer-centric innovation and patience value. Dominque is a published author, a panelist and keynote speaker.

She is also a certified executive coach and helps clients find purpose at cross-roads critical times.

Dominque sits on the boards of private and public companies. has been on many global councils for commercial excellence, patient centricity, as well as diversity. She is on the board of SAMA (Strategic Account Management Association) since 2011, part of WIB (Women in Bio) executive women group amongst others.